Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 36

1.

CENTRAL RETINAL VEIN OCCLUSION IN OTHERWISE HEALTHY CHILDREN AND ADOLESCENTS: Association With Multigenetic Variants of Thrombophilia.

Bremond-Gignac D, Daruich A, Gallet M, Menoud PA, Nowomiejska K, Rejdak R, Behar-Cohen F, Benkhalifa M, Copin H.

Retina. 2019 May 14. doi: 10.1097/IAE.0000000000002563. [Epub ahead of print]

PMID:
31095065
2.

Macular Hole Complicating Familial Exudative Vitreoretinopathy Due to LRP5 Mutation in an Adolescent.

Munier FL, Daruich A.

Ophthalmic Surg Lasers Imaging Retina. 2019 Feb 1;50(2):e49-e51. doi: 10.3928/23258160-20190129-19.

PMID:
30768230
3.

Iron is neurotoxic in retinal detachment and transferrin confers neuroprotection.

Daruich A, Le Rouzic Q, Jonet L, Naud MC, Kowalczuk L, Pournaras JA, Boatright JH, Thomas A, Turck N, Moulin A, Behar-Cohen F, Picard E.

Sci Adv. 2019 Jan 9;5(1):eaau9940. doi: 10.1126/sciadv.aau9940. eCollection 2019 Jan.

4.

Ophthalmic Insert versus Eye Drops for Mydriasis in Neonates: A Randomized Clinical Trial.

Bremond-Gignac D, Jacqz-Aigrain E, Abdoul H, Daruich A, Beresniak A, Baud O, Alberti C; on behalf of the CLAIR FO Study Group.

Neonatology. 2019;115(2):142-148. doi: 10.1159/000493723. Epub 2018 Nov 27.

PMID:
30481790
5.

CHANGES IN VISUAL ACUITY AND PHOTORECEPTOR DENSITY USING ADAPTIVE OPTICS AFTER RETINAL DETACHMENT REPAIR.

Potic J, Bergin C, Giacuzzo C, Daruich A, Pournaras JA, Kowalczuk L, Behar-Cohen F, Konstantinidis L, Wolfensberger TJ.

Retina. 2018 Nov 16. doi: 10.1097/IAE.0000000000002378. [Epub ahead of print]

PMID:
30475787
6.

Two-year follow-up of mineralocorticoid receptor antagonists for chronic central serous chorioretinopathy.

Zola M, Daruich A, Matet A, Mantel I, Behar-Cohen F.

Br J Ophthalmol. 2018 Oct 24. pii: bjophthalmol-2018-312892. doi: 10.1136/bjophthalmol-2018-312892. [Epub ahead of print]

PMID:
30355720
7.

EVOLUTION AND PATTERNS OF CHOROIDAL THICKNESS CHANGES IN RHEGMATOGENOUS RETINAL DETACHMENT.

Giacuzzo C, Bergin C, Potic J, Forestier E, Daruich A, Pournaras JA, Konstantinidis L, Wolfensberger TJ.

Retina. 2018 Oct 9. doi: 10.1097/IAE.0000000000002345. [Epub ahead of print]

PMID:
30308562
8.

Hemi-macular detachment: EnFace optical coherence tomography characteristics and clinical implications.

Potic J, Bergin C, Giacuzzo C, Daruich A, Pournaras JA, Konstantinidis L, Wolfensberger TJ.

Acta Ophthalmol. 2019 Feb;97(1):e129-e130. doi: 10.1111/aos.13727. Epub 2018 Sep 5. No abstract available.

PMID:
30187665
9.

PATTERNS OF CHORIOCAPILLARIS FLOW SIGNAL VOIDS IN CENTRAL SEROUS CHORIORETINOPATHY: An Optical Coherence Tomography Angiography Study.

Matet A, Daruich A, Hardy S, Behar-Cohen F.

Retina. 2018 Jul 17. doi: 10.1097/IAE.0000000000002271. [Epub ahead of print]

PMID:
30028410
10.

Discrepancy in current central serous chorioretinopathy classification.

Singh SR, Matet A, van Dijk EHC, Daruich A, Fauser S, Yzer S, Peiretti E, Sivaprasad S, Lotery AJ, Boon CJF, Behar-Cohen F, Freund KB, Chhablani J.

Br J Ophthalmol. 2019 Jun;103(6):737-742. doi: 10.1136/bjophthalmol-2018-312435. Epub 2018 Jul 12.

PMID:
30002069
11.

INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR TREATMENT AT 2-MONTH INTERVALS REDUCES FOVEAL AVASCULAR ZONE ENLARGEMENT AND VISION LOSS IN RADIATION MACULOPATHY: A Pilot Study.

Daruich A, Matet A, Schalenbourg A, Zografos L.

Retina. 2018 May 3. doi: 10.1097/IAE.0000000000002200. [Epub ahead of print]

PMID:
29746413
12.

Central Scotoma after Removal of Silicone Oil in Retinal Detachment: A Multimodal Imaging Case Report.

Giacuzzo C, Potic J, Wolfensberger TJ, Daruich A.

Klin Monbl Augenheilkd. 2018 Apr;235(4):498-500. doi: 10.1055/s-0043-123643. Epub 2018 Feb 28. No abstract available.

PMID:
29490394
13.

Proteome and Metabolome of Subretinal Fluid in Central Serous Chorioretinopathy and Rhegmatogenous Retinal Detachment: A Pilot Case Study.

Kowalczuk L, Matet A, Dor M, Bararpour N, Daruich A, Dirani A, Behar-Cohen F, Thomas A, Turck N.

Transl Vis Sci Technol. 2018 Jan 18;7(1):3. doi: 10.1167/tvst.7.1.3. eCollection 2018 Jan.

14.

Cataract development in children with Coats disease: risk factors and outcome.

Daruich A, Matet A, Munier FL.

J AAPOS. 2018 Feb;22(1):44-49. doi: 10.1016/j.jaapos.2017.09.009. Epub 2017 Dec 29.

PMID:
29289688
15.

Primary rhegmatogenous retinal detachment: risk factors for macular involvement.

Potic J, Bergin C, Giacuzzo C, Daruich A, Konstantinidis L, Wolfensberger TJ.

Graefes Arch Clin Exp Ophthalmol. 2018 Mar;256(3):489-494. doi: 10.1007/s00417-017-3880-x. Epub 2017 Dec 28.

PMID:
29282564
16.

Mechanisms of macular edema: Beyond the surface.

Daruich A, Matet A, Moulin A, Kowalczuk L, Nicolas M, Sellam A, Rothschild PR, Omri S, Gélizé E, Jonet L, Delaunay K, De Kozak Y, Berdugo M, Zhao M, Crisanti P, Behar-Cohen F.

Prog Retin Eye Res. 2018 Mar;63:20-68. doi: 10.1016/j.preteyeres.2017.10.006. Epub 2017 Nov 7. Review.

17.

Irvine-Gass Macular Edema Responding to the Combination of Oral Mineralocorticoid-Receptor Antagonist With Dexamethasone Drops.

Matet A, Daruich A, Behar-Cohen F.

Ophthalmic Surg Lasers Imaging Retina. 2017 Nov 1;48(11):936-942. doi: 10.3928/23258160-20171030-11.

PMID:
29121365
18.

YOUNGER AGE AT PRESENTATION IN CHILDREN WITH COATS DISEASE IS ASSOCIATED WITH MORE ADVANCED STAGE AND WORSE VISUAL PROGNOSIS: A Retrospective Study.

Daruich A, Matet A, Munier FL.

Retina. 2018 Nov;38(11):2239-2246. doi: 10.1097/IAE.0000000000001866.

PMID:
29065013
19.

CONCURRENT IDIOPATHIC MACULAR TELANGIECTASIA TYPE 2 AND CENTRAL SEROUS CHORIORETINOPATHY.

Matet A, Yzer S, Chew EY, Daruich A, Behar-Cohen F, Spaide RF.

Retina. 2018 Jan;38 Suppl 1:S67-S78. doi: 10.1097/IAE.0000000000001836.

20.

Radiation Maculopathy After Proton Beam Therapy for Uveal Melanoma: Optical Coherence Tomography Angiography Alterations Influencing Visual Acuity.

Matet A, Daruich A, Zografos L.

Invest Ophthalmol Vis Sci. 2017 Aug 1;58(10):3851-3861. doi: 10.1167/iovs.17-22324.

21.

[Ophthalmology in 2016 : the advent of ocular biomarkers].

Matet A, Daruich A, Behar-Cohen F.

Rev Med Suisse. 2017 Jan 11;13(544-545):84-87. Review. French.

PMID:
28703544
22.

RISK FACTORS FOR RECURRENCES OF CENTRAL SEROUS CHORIORETINOPATHY.

Matet A, Daruich A, Zola M, Behar-Cohen F.

Retina. 2018 Jul;38(7):1403-1414. doi: 10.1097/IAE.0000000000001729.

PMID:
28570485
23.

Central Serous Chorioretinopathy.

Daruich A, Matet A, Behar-Cohen F.

Dev Ophthalmol. 2017;58:27-38. doi: 10.1159/000455267. Epub 2017 Mar 28. Review.

PMID:
28351043
24.

ACUTE CENTRAL SEROUS CHORIORETINOPATHY: Factors Influencing Episode Duration.

Daruich A, Matet A, Marchionno L, De Azevedo JD, Ambresin A, Mantel I, Behar-Cohen F.

Retina. 2017 Oct;37(10):1905-1915. doi: 10.1097/IAE.0000000000001443.

25.

SUBFOVEAL NODULE IN COATS' DISEASE: Toward an Updated Classification Predicting Visual Prognosis.

Daruich AL, Moulin AP, Tran HV, Matet A, Munier FL.

Retina. 2017 Aug;37(8):1591-1598. doi: 10.1097/IAE.0000000000001399.

26.

EFFICACY OF INTRAVITREAL AFLIBERCEPT IN MACULAR TELANGIECTASIA TYPE 1 IS LINKED TO THE OCULAR ANGIOGENIC PROFILE.

Kowalczuk L, Matet A, Dirani A, Daruich A, Ambresin A, Mantel I, Spaide RF, Turck N, Behar-Cohen F.

Retina. 2017 Dec;37(12):2226-2237. doi: 10.1097/IAE.0000000000001424.

27.

Retinal safety of intravitreal rtPA in healthy rats and under excitotoxic conditions.

Daruich A, Parcq J, Delaunay K, Naud MC, Le Rouzic Q, Picard E, Crisanti P, Vivien D, Berdugo M, Behar-Cohen F.

Mol Vis. 2016 Nov 10;22:1332-1341. eCollection 2016.

28.

Macular Telangiectasia Type 1: Capillary Density and Microvascular Abnormalities Assessed by Optical Coherence Tomography Angiography.

Matet A, Daruich A, Dirani A, Ambresin A, Behar-Cohen F.

Am J Ophthalmol. 2016 Jul;167:18-30. doi: 10.1016/j.ajo.2016.04.005. Epub 2016 Apr 12.

PMID:
27084003
29.

EXTRAMACULAR FIBROSIS IN COATS' DISEASE.

Daruich A, Matet A, Tran HV, Gaillard MC, Munier FL.

Retina. 2016 Oct;36(10):2022-8. doi: 10.1097/IAE.0000000000001013.

PMID:
26991649
30.

Oral Mineralocorticoid-Receptor Antagonists: Real-Life Experience in Clinical Subtypes of Nonresolving Central Serous Chorioretinopathy With Chronic Epitheliopathy.

Daruich A, Matet A, Dirani A, Gallice M, Nicholson L, Sivaprasad S, Behar-Cohen F.

Transl Vis Sci Technol. 2016 Mar 4;5(2):2. eCollection 2016 Mar.

31.

Sustained-release steroids for the treatment of diabetic macular edema.

Daruich A, Matet A, Behar-Cohen F.

Curr Diab Rep. 2015 Nov;15(11):99. doi: 10.1007/s11892-015-0669-3. Review.

32.

The Eye on Mitochondrial Disorders.

Finsterer J, Zarrouk-Mahjoub S, Daruich A.

J Child Neurol. 2016 Apr;31(5):652-62. doi: 10.1177/0883073815599263. Epub 2015 Aug 14. Review.

33.

Systemic adalimumab induces peripheral corneal infiltrates: a case report.

Matet A, Daruich A, Beydoun T, Cosnes J, Bourges JL.

BMC Ophthalmol. 2015 Jun 6;15:57. doi: 10.1186/s12886-015-0047-6.

34.

Central serous chorioretinopathy: Recent findings and new physiopathology hypothesis.

Daruich A, Matet A, Dirani A, Bousquet E, Zhao M, Farman N, Jaisser F, Behar-Cohen F.

Prog Retin Eye Res. 2015 Sep;48:82-118. doi: 10.1016/j.preteyeres.2015.05.003. Epub 2015 May 27. Review.

35.
36.

[Severe bacterial keratitis referred to ophthalmology emergency departments: a retrospective study of 268 cases].

Dethorey G, Daruich A, Hay A, Renard G, Bourges JL.

J Fr Ophtalmol. 2013 Feb;36(2):129-37. doi: 10.1016/j.jfo.2011.12.013. Epub 2012 Sep 25. French.

Supplemental Content

Loading ...
Support Center